0001193125-23-149921 Sample Contracts

ATHIRA PHARMA, INC. CHANGE IN CONTROL AND SEVERANCE AGREEMENT

Change in Control and Severance Agreement • May 22nd, 2023 • Athira Pharma, Inc. • Biological products, (no disgnostic substances) • Washington

• Contract Type
  Change in Control and Severance Agreement
• Filed
  May 22nd, 2023
• Company
  Athira Pharma, Inc.
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  Washington

This Change in Control and Severance Agreement (the “Agreement”) is made by and between Athira Pharma, Inc., a Delaware corporation (the “Company”), and Andrew Gengos (“Executive”), effective as of May 18, 2023 (the “Effective Date”).

TRANSITION AGREEMENT AND RELEASE

Transition Agreement and Release • May 22nd, 2023 • Athira Pharma, Inc. • Biological products, (no disgnostic substances) • Washington

• Contract Type
  Transition Agreement and Release
• Filed
  May 22nd, 2023
• Company
  Athira Pharma, Inc.
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  Washington

This Transition Agreement and Release (“Agreement”) is made by and between Glenna Mileson (“Employee”) and Athira Pharma, Inc. (the “Company”) (collectively referred to as the “Parties” or individually referred to as a “Party”).